Skip to main content

Ipamorelin Therapy

Meaning

Ipamorelin therapy involves the clinical administration of Ipamorelin, a synthetic pentapeptide that functions as a highly selective and potent growth hormone secretagogue (GHS). This therapeutic approach is precisely designed to stimulate the body’s natural, pulsatile release of endogenous growth hormone (GH) from the anterior pituitary gland. Ipamorelin is clinically favored for its ability to induce GH secretion without significantly increasing the concurrent release of cortisol, prolactin, or adrenocorticotropic hormone (ACTH), offering a much cleaner and more physiological profile than older agents. The therapy is utilized to potentially enhance lean body composition, support accelerated tissue repair, and improve overall vitality and recovery.